Dr. Reddy’s Earnings Indicate Tough Quarter Ahead For Indian Generics In  U.S.
Brightly coloured pharmaceutical medication, including antibiotics, are arranged for a photograph. (Photographer: Chris Ratcliffe/Bloomberg)

Dr. Reddy’s Earnings Indicate Tough Quarter Ahead For Indian Generics In U.S.

Dr. Reddy’s Laboratories’ September quarter results indicate that pricing pressure and intense competition are hurting profitability of Indian generic drugmakers in the U.S., their largest market.U...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.